郭明洲, 博士, 1986月7月 畢業於河南醫科大學臨床醫學系獲醫學學士學位。1992年7月畢業於河南醫科大學醫學系消化專業獲醫學碩士學位。
基本介紹
- 中文名稱：郭明洲
- 國籍：中國
- 職業：醫生
- 畢業院校：河南醫科大學
- 學歷：博士
人物介紹,學術研究,學術兼職,研究方向,
人物介紹
1998月7月畢業於同濟醫科大學醫學系消化專業獲醫學博士學位 。1999年1月—2006.6在美國約翰霍普金斯大學腫瘤中心從事博士後研究工作。2005年至今被聘為鄭州大學特聘教授。2007年5月至今被聘為中國人民解放軍總醫院消化科研究員。主要從事腫瘤表觀遺傳學（Epigenetics）方面的研究，特別是消化系統腫瘤的表觀遺傳學研究。在<<Newengland Journal of Medicine>>等國際學術期刊已發表論文（SCI）60餘篇。主編中文專著一部，編寫英文章節的專著兩部。申請專利3項。目前承擔973、863、國家重點科學儀器專項、國家自然科學基金面上項目、國家自然科學基金創新群體基金、國家自然科學基金中美合作基金等項目。
學術研究
歷與研究經歷：
學士
1981月9月- 1986月6月
河南醫科大學 鄭州450052
碩士
1989 月9月- 1992月6月
河南醫科大學第二附屬醫院消化內科 鄭州450052
博士
1995年9月- 1998 年6月
同濟醫科大學協和醫院消化科 武漢 430022
博士後
1998年12月—2006.4
美國約翰霍普金斯大學腫瘤中心
工作經歷：
1986年7月-1989年8月
河南省鄭州市二院 住院醫生 鄭州450000
1992月6 月- 1995月8月
河南醫科大學消化研究所，河南醫科大學二附院 消化內科
主治醫師，講師 鄭州450053
2005-至今： 鄭州大學 教授
2006年-2008 年
美國約翰霍普金斯大學腫瘤中心 副研究員
2008年－至今：中國人民解放軍總醫院 研究員，教授
1981月9月- 1986月6月
河南醫科大學 鄭州450052
碩士
1989 月9月- 1992月6月
河南醫科大學第二附屬醫院消化內科 鄭州450052
博士
1995年9月- 1998 年6月
同濟醫科大學協和醫院消化科 武漢 430022
博士後
1998年12月—2006.4
美國約翰霍普金斯大學腫瘤中心
工作經歷：
1986年7月-1989年8月
河南省鄭州市二院 住院醫生 鄭州450000
1992月6 月- 1995月8月
河南醫科大學消化研究所，河南醫科大學二附院 消化內科
主治醫師，講師 鄭州450053
2005-至今： 鄭州大學 教授
2006年-2008 年
美國約翰霍普金斯大學腫瘤中心 副研究員
2008年－至今：中國人民解放軍總醫院 研究員，教授
學術兼職
1992 年6月 -2005 胃腸病學和肝病學雜誌 編輯、編輯部主任
2005 年－2007 胃腸病學和肝病學雜誌 常務副主編
2007- 至今 胃腸病學和肝病學雜誌 共同主編
2012年-2016年 胃腸病學 編委
2011年-2014年 中華消化協會腫瘤學組 委員
2012年-2014年 中國抗癌協會腫瘤納米學會 委員
2005 年－2007 胃腸病學和肝病學雜誌 常務副主編
2007- 至今 胃腸病學和肝病學雜誌 共同主編
2012年-2016年 胃腸病學 編委
2011年-2014年 中華消化協會腫瘤學組 委員
2012年-2014年 中國抗癌協會腫瘤納米學會 委員
研究方向
長期從事腫瘤的分子診斷及發病機制的研究，特別是在腫瘤表觀遺傳學方面具有一定的研究積累，對食管癌等消化道腫瘤進行了大量研究。
目前承擔以下課題：
1. 功能納米材料與腫瘤細胞外基質的相互作用——對腫瘤惡性表型調控作用研究 （973）
2. 腫瘤非編碼RNA轉錄加工相關蛋白的功能研究 (973)（課題負責人）
3. 食管癌的“基因-環境互作”“組學”研究
4. 食管癌中DNA甲基化、組蛋白修飾和miRNA對Sox17的轉錄調控（國家自然科學基金面上項目） （課題負責人）
5. 平行研究在大鼠和人食管癌前病變中MAPK,NFkB 和氧化應激通路的作用（國家自然科學基金面上項目中美合作基金） 81161120432（30萬）（課題負責人）
6. 腫瘤微環境細胞的高通量分選、高效率轉染及無標記檢測系統平台（國家科學儀器重大專項） （課題負責人）
7. 胃癌分子分型和個體化診療技術（863）
8. 胃癌的"組學"整合研究（863）
9. 嚴重創傷機體重要組織和器官損傷修復與再生研究（國家自然科學基金創新群體基金）
目前承擔以下課題：
1. 功能納米材料與腫瘤細胞外基質的相互作用——對腫瘤惡性表型調控作用研究 （973）
2. 腫瘤非編碼RNA轉錄加工相關蛋白的功能研究 (973)（課題負責人）
3. 食管癌的“基因-環境互作”“組學”研究
4. 食管癌中DNA甲基化、組蛋白修飾和miRNA對Sox17的轉錄調控（國家自然科學基金面上項目） （課題負責人）
5. 平行研究在大鼠和人食管癌前病變中MAPK,NFkB 和氧化應激通路的作用（國家自然科學基金面上項目中美合作基金） 81161120432（30萬）（課題負責人）
6. 腫瘤微環境細胞的高通量分選、高效率轉染及無標記檢測系統平台（國家科學儀器重大專項） （課題負責人）
7. 胃癌分子分型和個體化診療技術（863）
8. 胃癌的"組學"整合研究（863）
9. 嚴重創傷機體重要組織和器官損傷修復與再生研究（國家自然科學基金創新群體基金）
Peer review papers（發表的英文論文）
1. Liu X, Zhang X, Zhan Q, Brock M, Herman JG, Guo M. CDX2 serves as a Wnt signaling inhibitor and is frequently methylated in lung cancer. Cancer Biol Ther. 2012 Oct 1;13(12). [Epub ahead of print] (correspondence)
2. Yin D, Jia Y, Yu Y, Brock MV, Herman JG, Han C, Su X, Liu Y, Guo M. SOX17 methylation inhibits its antagonism of Wnt signaling pathway in lung cancer. Discov Med. 2012 Jul;14(74):33-40. (correspondence)
3. Jia Y, Yang Y, Brock MV, Zhan Q, Herman JG, Guo M. Epigenetic Regulation of DACT2, A Key Component of the Wnt Signaling Pathway in Human Lung Cancer. J Pathol. 2012 Jul 18. doi: 10.1002/path.4073. [Epub ahead of print] (correspondence)
4. Yan Jia,Yunsheng Yang, Qimin Zhan, Hongbin Zhu, Yuanzi Yu, James G. Herman△ and Mingzhou Guo△MicroRNA-141 and Methylation Regulation of WNT Signal Pathway by Suppressing SOX17 in Esophageal Cancer. Journal of Molecular Diagnosis. 14 (6): 2012. (In Press) (correspondence)
5. Yan WJ, Guo MZ, Yang YS. [The role of hypermethylation in promoter region of ubiquitin carboxyl-terminal hydrolase L1 in human esophageal cancer]. Zhonghua Nei Ke Za Zhi. 2012 May;51(5):390-3.
6. Chen T, Yan F, Qian J, Guo M, Zhang H, Tang X, Chen F, Stoner GD, Wang X. Randomized phase II trial of lyophilized strawberries in patients with dysplastic precancerous lesions of the esophagus. Cancer Prev Res (Phila). 2012 Jan;5(1):41-50. Epub 2011 Dec 1.
7. Ning B, Liu G, Liu Y, Su X, Anderson GJ, Zheng X, Chang Y, Guo M, Liu Y, Zhao Y, Nie G. 5-aza-2'-deoxycytidine activates iron uptake and heme biosynthesis by increasing c-Myc nuclear localization and binding to the E-boxes of transferrin receptor 1 (TfR1) and ferrochelatase (Fech) genes. J Biol Chem. 2011 Oct 28;286(43):37196-206. Epub 2011 Sep 7.
8. Chen YH, Wu ZQ, Zhao YL, Si YL, Guo MZ, Han WD. FHL2 inhibits the Id3-promoted proliferation and invasive growth of human MCF-7 breast cancer cells. Chin Med J (Engl). 2012 Jul;125(13):2329-33.
9. Chen XY, He QY, Guo MZ. XAF1 is frequently methylated in human esophageal cancer. World J Gastroenterol. 2012 Jun 14;18(22):2844-9. (correspondence)
10. Jia Y, Yang Y, Liu S, Herman JG, Lu F, Guo M. SOX17 antagonizes WNT/beta-catenin signaling pathway in hepatocellular carcinoma. Epigenetics. 2010 Nov-Dec;5(8):743-9. Epub 2010 Nov 22. (correspondence)
11. Jia Y, Yang Y, Brock MV, Cao B, Zhan Q, Li Y, Yu Y, Herman JG, Guo M. Methylation of TFPI-2 is an early event of esophageal carcinogenesis. Epigenomics. 2012 Apr;4(2):135-46. (correspondence)
12. Deng YZ, Yao F, Li JJ, Mao ZF, Hu PT, Long LY, Li G, Ji XD, Shi S, Guan DX, Feng YY, Cui L, Li DS, Liu Y, Du X, Guo MZ, Xu LY, Li EM, Wang HY, Xie D. RACK1 Suppresses Gastric Tumorigenesis by Stabilizing the β-Catenin Destruction Complex. Gastroenterology. 2012 Apr;142(4):812-823.e15. Epub 2012 Jan 10.
13. Yu Y, Yin D, Hoque MO, Cao B, Jia Y, Yang Y, Guo M. Tumour Biol. AKT signaling pathway activated by HIN-1 methylation in non-small cell lung cancer. Tumour Biol. 2012 Apr;33(2):307-14.. (correspondence)
14. Jia Y, Guo M. Epigenetic changes in colorectal cancer. Chin J Cancer. 2011 Nov 4. doi: 10.5732/cjc.011.10245. [Epub ahead of print]PMID:22059907[PubMed - as supplied by publisher] (correspondence)
15. Xiao-Mei Zhang and Ming-Zhou Guo . The value of epigenetic markers in esophageal cancer. Front Med China 4(4):378-84 (2010) Review. (correspondence)
16. Gong Y, Yang YS, Zhang XM, Su M, Wang J, Han JD, Guo MZ. ABO blood type, diabetes and risk of gastrointestinal cancer in northern China. World J Gastroenterol. 2012 Feb 14;18(6):563-9.
(correspondence) .
17. Ying Chen, Chun-min Yang, Gao-ping Mao, Qing-sen Liu and Ming-zhou Guo. Effects of simulated weightlessness on the intestinal mucosal barrier of rats. J Huazhong Univ Sci Technolog Med Sci. 2011 Feb;31(1):26-32. Epub 2011 Feb 19)
18. Hou J, Li EM, Shen JH, Qing-Zhao, Wu ZY, Xu XE, Wu JY, Qiao-Huang, Shen J, Guo MZ, Xu LY. Cytoplasmic HDPR1 is involved in regional lymph node metastasis and tumor development via beta-catenin accumulation in esophageal squamous cell carcinoma. J Histochem Cytochem. 2011 Jul;59(7):711-8. Epub 2011 Apr 27. (Co-correspondence).
19. Wang J, Zhao W, Cheng L, Guo M, Li D, Li X, Tan Y, Ma S, Li S, Yang Y, Chen L, Wang S. CD137-mediated pathogenesis from chronic hepatitis to hepatocellular carcinoma in hepatitis B virus-transgenic mice. J Immunol. 2010 Dec 15;185(12):7654-62. Epub 2010 Nov 8.
20. Ye Zhao, Jian-Sheng Li, Ming-Zhou Guo, Bai-Sui Feng and Jin-Ping Zhang Inhibitory effect of S-adenosylmethionine on the growth of human gastric cancer cells in vivo and in vitro. Chin J Cancer 29(8):752-60
21. Wang M, Cheng Z, Tian T, Chen J, Dou F, Guo M, Cong YS. Differential expression of oncogenic miRNAs in proliferating and senescent human fibroblasts. Mol Cell Biochem. 2011 Mar 17. [Epub ahead of print]
22. Zhao Y, Li JS, Guo MZ, Feng BS, Zhang JP, Chen XY. Effects of S-adenosylmethionine on gastric cancer cell lines SGC-7901 and BGC-823. Zhonghua Yi Xue Za Zhi. 2010 Jun 8;90(22):1559-64.
23. Zhang XL, Yang YS, Sun G, Guo MZ. Natural orifice translumenal endoscopic surgery (NOTES): current status and challenges.Chin Med J (Engl). 2010 Jan 20;123(2):244-7. Review
24. Guo M, Ren J, Brock MV, Herman JG, Carraway HE. Promoter methylation of HIN-1 in the progression to esophageal squamous cancer. Epigenetics. 2008 Nov;3(6):336-41. Epub 2008 Nov 8.
25. Guo M, House MG, Suzuki H, Ye Y, Brock MV, Lu F, Liu Z, Rustgi AK, Herman JG. Epigenetic silencing of CDX2 is a feature of squamous esophageal cancer. Int J Cancer. 2007 Sep 15;121(6):1219-26.
26. Guo M, Liu S, Lu F. Gefitinib-sensitizing mutations in esophageal carcinoma. N Engl J Med. 2006 May 18;354(20):2193-4.
27. Guo M, House MG, Akiyama Y, Qi Y, Capagna D, Harmon J, Baylin SB, Brock MV, Herman JG. Hypermethylation of the GATA gene family in esophageal cancer. Int J Cancer. 2006 Jul 5;119(9):2078-2083
28. Guo M, Ren J, House MG, Qi Y, Brock MV, Herman JG. Accumulation of promoter methylation suggests epigenetic progression in squamous cell carcinoma of the esophagus. Clin Cancer Res. 2006 Aug 1;12(15):4515-22.
29. Guo M, House MG, Hooker C, Han Y, Heath E, Gabrielson E, Yang SC, Baylin SB, Herman JG, Brock MV. Promoter hypermethylation of resected bronchial margins: a field defect of changes? Clin Cancer Res. 10: 5131-5136, 2004.
30. Guo M, Akiyama Y, House MG, Hooker CM, Heath E, Gabrielson E, Yang SC, Han Y, Baylin SB, Herman JG, Brock MV. Hypermethylation of the GATA genes in lung cancer. Clin Cancer Res. 10:7917-7924, 2004.
31. Guo M, Liu S, Herman, JG, Zhuang, H Lu, F. Gefitinib-Sensitizing Mutation in Esophageal Carcinoma Cell Line Kyse450. Cancer Biol Ther. 2006 Feb;5(2):152-5.
32. Wang JS, Guo M, Montgomery EA, Thompson RE, Cosby H, Hicks L, Wang S, Herman JG, Canto MI. DNA Promoter Hypermethylation of p16 and APC Predicts Neoplastic Progression in Barrett's Esophagus. Am J Gastroenterol. 2009 Jul 7. [Epub ahead of print]
33. Ye Y, McDevitt MA, Guo M, Zhang W, Galm O, Gore SD, Karp JE, Maciejewski JP, Kowalski J, Tsai HL, Gondek LP, Tsai HC, Wang X, Hooker C, Smith BD, Carraway HE, Herman JG. Progressive chromatin repression and promoter methylation of CTNNA1 associated with advanced myeloid malignancies. Cancer Res. 2009 Nov 1;69(21):8482-90. Epub 2009 Oct 13.
34. Yang B, Guo M, Herman JG, Clark DP. Aberrant promoter methylation profiles of tumor suppressor genes in hepatocellular carcinoma. Am J Pathol. 163:1101-1107, 2003. ( first author equal contribution)
35. Riojas MA, Guo M, Glöckner SC, Machida EO, Baylin SB, Ahuja N. Methylation-Induced Silencing of ASC/TMS1, a Pro-Apoptotic Gene, is a Late-Stage Event in Colorectal Cancer. Cancer Biol Ther. 2007 Nov;6(11):1710-6. Epub 2007 Aug 3. ( first author equal contribution)
36. Fu B, Guo M, Wang S, Campagna D, Luo M, Herman JG, Iacobuzio-Donahue CA. Evaluation of GATA-4 and GATA-5 Methylation Profiles in Human Pancreatic Cancers Indicate Promoter Methylation Patterns Distinct from other Human Tumor Types. Cancer Biol Ther. 2007 Oct;6(10):1546-52.
37. Esteller M, Guo M, Moreno V, Peinado MA, Capella G, Galm O, Baylin SB, Herman JG. Hypermethylation associated Inactivation of the Cellular Retinol-Binding-Protein 1 Gene in Human Cancer. Cancer Res. 6 :5902-5905, 2002.
38. House MG, Guo M, Efron DT, Lillemoe KD, Cameron JL, Syphard JE, Hooker CM, Abraham SC, Montgomery EA, Herman JG, Brock MV. Tumor suppressor gene hypermethylation as a predictor of gastric stromal tumor behavior. J Gastrointest Surg. 7:1004-1014, 2003.
39. Brock MV, Gou M, Akiyama Y, Muller A, Wu TT, Montgomery E, Deasel M, Germonpre P, Rubinson L, Heitmiller RF, Yang SC, Forastiere AA, Baylin SB, Herman JG. Prognostic importance of promoter hypermethylation of multiple genes in esophageal adenocarcinoma. Clin Cancer Res. 9:2912-2919, 2003.
40. House MG, Guo M, Iacobuzio-Donahue C, Herman JG. Molecular progression of promoter methylation in intraductal papillary mucinous neoplasms (IPMN) of the pancreas. Carcinogenesis. 24:193-198, 2003.
41. Zhang W, Glöckner SC, Guo M, Machida EO, Wang DH, Easwaran H, Van Neste L, Herman JG, Schuebel KE, Watkins DN, Ahuja N, Baylin SB. Epigenetic inactivation of the canonical Wnt antagonist SRY-box containing gene 17 in colorectal cancer. Cancer Res. 2008 Apr 15;68(8):2764-72.
42. Carraway HE, Wang S, Blackford A, Guo M, Powers P, Jeter S, Davidson NE, Argani P, Terrell K, Herman JG, Lange JR. Promoter hypermethylation in sentinel lymph nodes as a marker for breast cancer recurrence. Breast Cancer Res Treat. 2008 Apr 11. [Epub ahead of print]
43. Brock MV, Hooker CM, Ota-Machida E, Han Y, Guo M, Ames S, Glöckner S, Piantadosi S, Gabrielson E, Pridham G, Pelosky K, Belinsky SA, Yang SC, Baylin SB, Herman JG. DNA methylation markers and early recurrence in stage I lung cancer. N Engl J Med. 2008 Mar 13;358(11):1118-28.
44. Liu ZM, Ding F, Guo MZ, Zhang LY, Wu M, Liu ZH. Down regulation of retinoic acid receptor-beta(2) expression is linked to aberrant methylation in esophageal squamous cell carcinoma cell lines. World J Gastroenterol. 10:771-775, 2004.
45. Benzeno S, Lu F, Guo M, Barbash O, Zhang F, Herman JG, Klein PS, Rustgi A, Diehl JA. Identification of mutations that disrupt phosphorylation-dependent nuclear export of cyclin D1. Oncogene. 2006 Oct 12;25(47):6291-303. [Epub ahead of print]
46. Esteller M, Fraga MF, Guo M, Garcia-Foncillas J, Hedenfalk I, Godwin AK, Trojan J, Vaurs-Barriere C, Bignon YJ, Ramus S, Benitez J, Caldes T, Akiyama Y, Yuasa Y, Launonen V, Canal MJ, Rodriguez R, Capella G, Peinado MA, Borg A, Aaltonen LA, Ponder BA, Baylin SB, Herman JG. DNA methylation patterns in hereditary human cancers mimic sporadic tumorigenesis. Hum Mol Genet.10:3001-3007, 2001.
47. House MG, Herman JG, Guo MZ, Hooker CM, Schulick RD, Cameron JL, Hruban RH, Maitra A, Yeo CJ. Prognostic value of hMLH1 methylation and microsatellite instability in pancreatic endocrine neoplasms. Surgery. 134:902-908, 2003.
48. House MG, Herman JG, Guo MZ, Hooker CM, Schulick RD, Lillemoe KD, Cameron JL, Hruban RH, Maitra A, Yeo CJ. Aberrant hypermethylation of tumor suppressor genes in pancreatic endocrine neoplasms. Ann Surg. 238:423-431, 2003.
49. Hong KM, Yang SH, Guo M, Herman JG, Jen J. Semiautomatic detection of DNA methylation at CpG islands. Biotechniques. 38:354-358, 2005.
50. Yang B, House MG, Guo M, Herman JG, Clark DP. Promoter methylation profiles of tumor suppressor genes in intrahepatic and extrahepatic cholangiocarcinoma. Mod Pathol. 18:412-420, 2005.
51. House MG, Wistuba II, Argani P, Guo M, Schulick RD, Hruban RH, Herman JG, Maitra A. Progression of gene hypermethylation in gallstone disease leading to gallbladder cancer. Ann Surg Oncol. 10:882-889, 2003.
52. Lu F, Chen H, Zhou C, Liu S, Guo M, Chen P, Zhuang H, Xie D, Wu S. T-type Ca(2+) channel expression in human esophageal carcinomas: A functional role in proliferation.
Cell Calcium. 2008 Jan;43(1):49-58. Epub 2007 May 25.
53. Yue W, Dacic S, Sun Q, Landreneau R, Guo M, Zhou W, Siegfried JM, Yu J, Zhang L. Frequent Inactivation of RAMP2, EFEMP1 and Dutt1 in Lung Cancer by Promoter Hypermethylation. Clin Cancer Res 2007 Aug 1;13(15 Pt 1):4336-44.
54. Paz MF, Fraga MF, Avila S, Guo M, Pollan M, Herman JG, Esteller M. A systematic profile of DNA methylation in human cancer cell lines. Cancer Res. 63:1114-1121, 2003.
55. Liu ZM, Zhang L, Ding F, Li J, Guo M, Li W, Wang Y, Yu Z, Zhan Q, Wu M, Liu Z. 5-Aza-2'-deoxycytidine induces retinoic acid receptor-beta(2) demethylation and growth inhibition in esophageal squamous carcinoma cells. Cancer Lett. 230:271-283, 2005.
56. Brock MV, Hooker CM, Yung R, Guo M, Han Y, Ames SE, Chang D, Yang SC, Mason D, Sussman M, Baylin SB, Herman JG. Can we improve the cytologic examination of malignant pleural effusions using molecular analysis? Ann Thorac Surg. 80:1241-1247, 2005.
57. Nacht M, Dracheva T, Gao Y, Fujii T, Chen Y, Player A, Akmaev V, Cook B, Dufault M, Zhang M, Zhang W, Guo M, Curran J, Han S, Sidransky D, Buetow K, Madden SL, Jen J. Molecular characteristics of non-small cell lung cancer. Proc Natl Acad Sci U S A. 2001.
58. Moreno-Bueno G, Hardisson D, Sanchez C, Sarrio D, Cassia R, Garcia-Rostan G, Prat J, Guo M, Herman JG, Matias-Guiu X, Esteller M, Palacios J. Abnormalities of the APC/beta-catenin pathway in endometrial cancer. Oncogene. 21:7981-90, 2002.
59. Esteller M, Fraga MF, Paz MF, Campo E, Colomer D, Novo FJ, Calasanz MJ, Galm O, Guo M, Benitez J, Herman JG. Cancer epigenetics and methylation. Science. 297:1807-1808, 2002.
60. Laiho P, Launonen V, Lahermo P, Esteller M, Guo M, Herman JG, Mecklin JP, Jarvinen H, Sistonen P, Kim KM, Shibata D, Houlston RS, Aaltonen LA. Low-level microsatellite instability in most colorectal carcinomas. Cancer Res. 62:1166-1170, 2002.
61. Caballero OL, Resto V, Patturajan M, Meerzaman D, Guo M, Engles J, Yochem R, Ratovitski E, Sidransky D, Jen J. Interaction and colocalization of PGP9.5 with JAB1 and p27(Kip1). Oncogene. 21:3003-3010, 2002.
62. Sarrio D, Moreno-Bueno G, Hardisson D, Sanchez-Estevez C, Guo M, Herman JG, Gamallo C, Esteller M, Palacios J. Epigenetic and genetic alterations of APC and CDH1 genes in lobular breast cancer: relationships with abnormal E-cadherin and catenin expression and microsatellite instability. Int J Cancer. 106:208-215, 2003.
Book Chapter
1. Epigenetics and Tumor Suppressor Genes
by MingZhou Guo, XueFeng Liu and WeiMin Zhang in the book "Tumor Suppressor Genes" edited by Yue Cheng, ISBN 978-953-307-879-3, InTech, February 2, 2012
2. Molecular Biology Character of Esophageal Cancer
by Mingzhou Guo, Yan Jia and Wenji Yan in the book "Esophageal Cancer - Cell and Molecular Biology, Biomarkers, Nutrition and Treatment" edited by Ferdous Rastgar Jazii, ISBN 978-953-51-0223-6, InTech, March 3, 2012
1. Liu X, Zhang X, Zhan Q, Brock M, Herman JG, Guo M. CDX2 serves as a Wnt signaling inhibitor and is frequently methylated in lung cancer. Cancer Biol Ther. 2012 Oct 1;13(12). [Epub ahead of print] (correspondence)
2. Yin D, Jia Y, Yu Y, Brock MV, Herman JG, Han C, Su X, Liu Y, Guo M. SOX17 methylation inhibits its antagonism of Wnt signaling pathway in lung cancer. Discov Med. 2012 Jul;14(74):33-40. (correspondence)
3. Jia Y, Yang Y, Brock MV, Zhan Q, Herman JG, Guo M. Epigenetic Regulation of DACT2, A Key Component of the Wnt Signaling Pathway in Human Lung Cancer. J Pathol. 2012 Jul 18. doi: 10.1002/path.4073. [Epub ahead of print] (correspondence)
4. Yan Jia,Yunsheng Yang, Qimin Zhan, Hongbin Zhu, Yuanzi Yu, James G. Herman△ and Mingzhou Guo△MicroRNA-141 and Methylation Regulation of WNT Signal Pathway by Suppressing SOX17 in Esophageal Cancer. Journal of Molecular Diagnosis. 14 (6): 2012. (In Press) (correspondence)
5. Yan WJ, Guo MZ, Yang YS. [The role of hypermethylation in promoter region of ubiquitin carboxyl-terminal hydrolase L1 in human esophageal cancer]. Zhonghua Nei Ke Za Zhi. 2012 May;51(5):390-3.
6. Chen T, Yan F, Qian J, Guo M, Zhang H, Tang X, Chen F, Stoner GD, Wang X. Randomized phase II trial of lyophilized strawberries in patients with dysplastic precancerous lesions of the esophagus. Cancer Prev Res (Phila). 2012 Jan;5(1):41-50. Epub 2011 Dec 1.
7. Ning B, Liu G, Liu Y, Su X, Anderson GJ, Zheng X, Chang Y, Guo M, Liu Y, Zhao Y, Nie G. 5-aza-2'-deoxycytidine activates iron uptake and heme biosynthesis by increasing c-Myc nuclear localization and binding to the E-boxes of transferrin receptor 1 (TfR1) and ferrochelatase (Fech) genes. J Biol Chem. 2011 Oct 28;286(43):37196-206. Epub 2011 Sep 7.
8. Chen YH, Wu ZQ, Zhao YL, Si YL, Guo MZ, Han WD. FHL2 inhibits the Id3-promoted proliferation and invasive growth of human MCF-7 breast cancer cells. Chin Med J (Engl). 2012 Jul;125(13):2329-33.
9. Chen XY, He QY, Guo MZ. XAF1 is frequently methylated in human esophageal cancer. World J Gastroenterol. 2012 Jun 14;18(22):2844-9. (correspondence)
10. Jia Y, Yang Y, Liu S, Herman JG, Lu F, Guo M. SOX17 antagonizes WNT/beta-catenin signaling pathway in hepatocellular carcinoma. Epigenetics. 2010 Nov-Dec;5(8):743-9. Epub 2010 Nov 22. (correspondence)
11. Jia Y, Yang Y, Brock MV, Cao B, Zhan Q, Li Y, Yu Y, Herman JG, Guo M. Methylation of TFPI-2 is an early event of esophageal carcinogenesis. Epigenomics. 2012 Apr;4(2):135-46. (correspondence)
12. Deng YZ, Yao F, Li JJ, Mao ZF, Hu PT, Long LY, Li G, Ji XD, Shi S, Guan DX, Feng YY, Cui L, Li DS, Liu Y, Du X, Guo MZ, Xu LY, Li EM, Wang HY, Xie D. RACK1 Suppresses Gastric Tumorigenesis by Stabilizing the β-Catenin Destruction Complex. Gastroenterology. 2012 Apr;142(4):812-823.e15. Epub 2012 Jan 10.
13. Yu Y, Yin D, Hoque MO, Cao B, Jia Y, Yang Y, Guo M. Tumour Biol. AKT signaling pathway activated by HIN-1 methylation in non-small cell lung cancer. Tumour Biol. 2012 Apr;33(2):307-14.. (correspondence)
14. Jia Y, Guo M. Epigenetic changes in colorectal cancer. Chin J Cancer. 2011 Nov 4. doi: 10.5732/cjc.011.10245. [Epub ahead of print]PMID:22059907[PubMed - as supplied by publisher] (correspondence)
15. Xiao-Mei Zhang and Ming-Zhou Guo . The value of epigenetic markers in esophageal cancer. Front Med China 4(4):378-84 (2010) Review. (correspondence)
16. Gong Y, Yang YS, Zhang XM, Su M, Wang J, Han JD, Guo MZ. ABO blood type, diabetes and risk of gastrointestinal cancer in northern China. World J Gastroenterol. 2012 Feb 14;18(6):563-9.
(correspondence) .
17. Ying Chen, Chun-min Yang, Gao-ping Mao, Qing-sen Liu and Ming-zhou Guo. Effects of simulated weightlessness on the intestinal mucosal barrier of rats. J Huazhong Univ Sci Technolog Med Sci. 2011 Feb;31(1):26-32. Epub 2011 Feb 19)
18. Hou J, Li EM, Shen JH, Qing-Zhao, Wu ZY, Xu XE, Wu JY, Qiao-Huang, Shen J, Guo MZ, Xu LY. Cytoplasmic HDPR1 is involved in regional lymph node metastasis and tumor development via beta-catenin accumulation in esophageal squamous cell carcinoma. J Histochem Cytochem. 2011 Jul;59(7):711-8. Epub 2011 Apr 27. (Co-correspondence).
19. Wang J, Zhao W, Cheng L, Guo M, Li D, Li X, Tan Y, Ma S, Li S, Yang Y, Chen L, Wang S. CD137-mediated pathogenesis from chronic hepatitis to hepatocellular carcinoma in hepatitis B virus-transgenic mice. J Immunol. 2010 Dec 15;185(12):7654-62. Epub 2010 Nov 8.
20. Ye Zhao, Jian-Sheng Li, Ming-Zhou Guo, Bai-Sui Feng and Jin-Ping Zhang Inhibitory effect of S-adenosylmethionine on the growth of human gastric cancer cells in vivo and in vitro. Chin J Cancer 29(8):752-60
21. Wang M, Cheng Z, Tian T, Chen J, Dou F, Guo M, Cong YS. Differential expression of oncogenic miRNAs in proliferating and senescent human fibroblasts. Mol Cell Biochem. 2011 Mar 17. [Epub ahead of print]
22. Zhao Y, Li JS, Guo MZ, Feng BS, Zhang JP, Chen XY. Effects of S-adenosylmethionine on gastric cancer cell lines SGC-7901 and BGC-823. Zhonghua Yi Xue Za Zhi. 2010 Jun 8;90(22):1559-64.
23. Zhang XL, Yang YS, Sun G, Guo MZ. Natural orifice translumenal endoscopic surgery (NOTES): current status and challenges.Chin Med J (Engl). 2010 Jan 20;123(2):244-7. Review
24. Guo M, Ren J, Brock MV, Herman JG, Carraway HE. Promoter methylation of HIN-1 in the progression to esophageal squamous cancer. Epigenetics. 2008 Nov;3(6):336-41. Epub 2008 Nov 8.
25. Guo M, House MG, Suzuki H, Ye Y, Brock MV, Lu F, Liu Z, Rustgi AK, Herman JG. Epigenetic silencing of CDX2 is a feature of squamous esophageal cancer. Int J Cancer. 2007 Sep 15;121(6):1219-26.
26. Guo M, Liu S, Lu F. Gefitinib-sensitizing mutations in esophageal carcinoma. N Engl J Med. 2006 May 18;354(20):2193-4.
27. Guo M, House MG, Akiyama Y, Qi Y, Capagna D, Harmon J, Baylin SB, Brock MV, Herman JG. Hypermethylation of the GATA gene family in esophageal cancer. Int J Cancer. 2006 Jul 5;119(9):2078-2083
28. Guo M, Ren J, House MG, Qi Y, Brock MV, Herman JG. Accumulation of promoter methylation suggests epigenetic progression in squamous cell carcinoma of the esophagus. Clin Cancer Res. 2006 Aug 1;12(15):4515-22.
29. Guo M, House MG, Hooker C, Han Y, Heath E, Gabrielson E, Yang SC, Baylin SB, Herman JG, Brock MV. Promoter hypermethylation of resected bronchial margins: a field defect of changes? Clin Cancer Res. 10: 5131-5136, 2004.
30. Guo M, Akiyama Y, House MG, Hooker CM, Heath E, Gabrielson E, Yang SC, Han Y, Baylin SB, Herman JG, Brock MV. Hypermethylation of the GATA genes in lung cancer. Clin Cancer Res. 10:7917-7924, 2004.
31. Guo M, Liu S, Herman, JG, Zhuang, H Lu, F. Gefitinib-Sensitizing Mutation in Esophageal Carcinoma Cell Line Kyse450. Cancer Biol Ther. 2006 Feb;5(2):152-5.
32. Wang JS, Guo M, Montgomery EA, Thompson RE, Cosby H, Hicks L, Wang S, Herman JG, Canto MI. DNA Promoter Hypermethylation of p16 and APC Predicts Neoplastic Progression in Barrett's Esophagus. Am J Gastroenterol. 2009 Jul 7. [Epub ahead of print]
33. Ye Y, McDevitt MA, Guo M, Zhang W, Galm O, Gore SD, Karp JE, Maciejewski JP, Kowalski J, Tsai HL, Gondek LP, Tsai HC, Wang X, Hooker C, Smith BD, Carraway HE, Herman JG. Progressive chromatin repression and promoter methylation of CTNNA1 associated with advanced myeloid malignancies. Cancer Res. 2009 Nov 1;69(21):8482-90. Epub 2009 Oct 13.
34. Yang B, Guo M, Herman JG, Clark DP. Aberrant promoter methylation profiles of tumor suppressor genes in hepatocellular carcinoma. Am J Pathol. 163:1101-1107, 2003. ( first author equal contribution)
35. Riojas MA, Guo M, Glöckner SC, Machida EO, Baylin SB, Ahuja N. Methylation-Induced Silencing of ASC/TMS1, a Pro-Apoptotic Gene, is a Late-Stage Event in Colorectal Cancer. Cancer Biol Ther. 2007 Nov;6(11):1710-6. Epub 2007 Aug 3. ( first author equal contribution)
36. Fu B, Guo M, Wang S, Campagna D, Luo M, Herman JG, Iacobuzio-Donahue CA. Evaluation of GATA-4 and GATA-5 Methylation Profiles in Human Pancreatic Cancers Indicate Promoter Methylation Patterns Distinct from other Human Tumor Types. Cancer Biol Ther. 2007 Oct;6(10):1546-52.
37. Esteller M, Guo M, Moreno V, Peinado MA, Capella G, Galm O, Baylin SB, Herman JG. Hypermethylation associated Inactivation of the Cellular Retinol-Binding-Protein 1 Gene in Human Cancer. Cancer Res. 6 :5902-5905, 2002.
38. House MG, Guo M, Efron DT, Lillemoe KD, Cameron JL, Syphard JE, Hooker CM, Abraham SC, Montgomery EA, Herman JG, Brock MV. Tumor suppressor gene hypermethylation as a predictor of gastric stromal tumor behavior. J Gastrointest Surg. 7:1004-1014, 2003.
39. Brock MV, Gou M, Akiyama Y, Muller A, Wu TT, Montgomery E, Deasel M, Germonpre P, Rubinson L, Heitmiller RF, Yang SC, Forastiere AA, Baylin SB, Herman JG. Prognostic importance of promoter hypermethylation of multiple genes in esophageal adenocarcinoma. Clin Cancer Res. 9:2912-2919, 2003.
40. House MG, Guo M, Iacobuzio-Donahue C, Herman JG. Molecular progression of promoter methylation in intraductal papillary mucinous neoplasms (IPMN) of the pancreas. Carcinogenesis. 24:193-198, 2003.
41. Zhang W, Glöckner SC, Guo M, Machida EO, Wang DH, Easwaran H, Van Neste L, Herman JG, Schuebel KE, Watkins DN, Ahuja N, Baylin SB. Epigenetic inactivation of the canonical Wnt antagonist SRY-box containing gene 17 in colorectal cancer. Cancer Res. 2008 Apr 15;68(8):2764-72.
42. Carraway HE, Wang S, Blackford A, Guo M, Powers P, Jeter S, Davidson NE, Argani P, Terrell K, Herman JG, Lange JR. Promoter hypermethylation in sentinel lymph nodes as a marker for breast cancer recurrence. Breast Cancer Res Treat. 2008 Apr 11. [Epub ahead of print]
43. Brock MV, Hooker CM, Ota-Machida E, Han Y, Guo M, Ames S, Glöckner S, Piantadosi S, Gabrielson E, Pridham G, Pelosky K, Belinsky SA, Yang SC, Baylin SB, Herman JG. DNA methylation markers and early recurrence in stage I lung cancer. N Engl J Med. 2008 Mar 13;358(11):1118-28.
44. Liu ZM, Ding F, Guo MZ, Zhang LY, Wu M, Liu ZH. Down regulation of retinoic acid receptor-beta(2) expression is linked to aberrant methylation in esophageal squamous cell carcinoma cell lines. World J Gastroenterol. 10:771-775, 2004.
45. Benzeno S, Lu F, Guo M, Barbash O, Zhang F, Herman JG, Klein PS, Rustgi A, Diehl JA. Identification of mutations that disrupt phosphorylation-dependent nuclear export of cyclin D1. Oncogene. 2006 Oct 12;25(47):6291-303. [Epub ahead of print]
46. Esteller M, Fraga MF, Guo M, Garcia-Foncillas J, Hedenfalk I, Godwin AK, Trojan J, Vaurs-Barriere C, Bignon YJ, Ramus S, Benitez J, Caldes T, Akiyama Y, Yuasa Y, Launonen V, Canal MJ, Rodriguez R, Capella G, Peinado MA, Borg A, Aaltonen LA, Ponder BA, Baylin SB, Herman JG. DNA methylation patterns in hereditary human cancers mimic sporadic tumorigenesis. Hum Mol Genet.10:3001-3007, 2001.
47. House MG, Herman JG, Guo MZ, Hooker CM, Schulick RD, Cameron JL, Hruban RH, Maitra A, Yeo CJ. Prognostic value of hMLH1 methylation and microsatellite instability in pancreatic endocrine neoplasms. Surgery. 134:902-908, 2003.
48. House MG, Herman JG, Guo MZ, Hooker CM, Schulick RD, Lillemoe KD, Cameron JL, Hruban RH, Maitra A, Yeo CJ. Aberrant hypermethylation of tumor suppressor genes in pancreatic endocrine neoplasms. Ann Surg. 238:423-431, 2003.
49. Hong KM, Yang SH, Guo M, Herman JG, Jen J. Semiautomatic detection of DNA methylation at CpG islands. Biotechniques. 38:354-358, 2005.
50. Yang B, House MG, Guo M, Herman JG, Clark DP. Promoter methylation profiles of tumor suppressor genes in intrahepatic and extrahepatic cholangiocarcinoma. Mod Pathol. 18:412-420, 2005.
51. House MG, Wistuba II, Argani P, Guo M, Schulick RD, Hruban RH, Herman JG, Maitra A. Progression of gene hypermethylation in gallstone disease leading to gallbladder cancer. Ann Surg Oncol. 10:882-889, 2003.
52. Lu F, Chen H, Zhou C, Liu S, Guo M, Chen P, Zhuang H, Xie D, Wu S. T-type Ca(2+) channel expression in human esophageal carcinomas: A functional role in proliferation.
Cell Calcium. 2008 Jan;43(1):49-58. Epub 2007 May 25.
53. Yue W, Dacic S, Sun Q, Landreneau R, Guo M, Zhou W, Siegfried JM, Yu J, Zhang L. Frequent Inactivation of RAMP2, EFEMP1 and Dutt1 in Lung Cancer by Promoter Hypermethylation. Clin Cancer Res 2007 Aug 1;13(15 Pt 1):4336-44.
54. Paz MF, Fraga MF, Avila S, Guo M, Pollan M, Herman JG, Esteller M. A systematic profile of DNA methylation in human cancer cell lines. Cancer Res. 63:1114-1121, 2003.
55. Liu ZM, Zhang L, Ding F, Li J, Guo M, Li W, Wang Y, Yu Z, Zhan Q, Wu M, Liu Z. 5-Aza-2'-deoxycytidine induces retinoic acid receptor-beta(2) demethylation and growth inhibition in esophageal squamous carcinoma cells. Cancer Lett. 230:271-283, 2005.
56. Brock MV, Hooker CM, Yung R, Guo M, Han Y, Ames SE, Chang D, Yang SC, Mason D, Sussman M, Baylin SB, Herman JG. Can we improve the cytologic examination of malignant pleural effusions using molecular analysis? Ann Thorac Surg. 80:1241-1247, 2005.
57. Nacht M, Dracheva T, Gao Y, Fujii T, Chen Y, Player A, Akmaev V, Cook B, Dufault M, Zhang M, Zhang W, Guo M, Curran J, Han S, Sidransky D, Buetow K, Madden SL, Jen J. Molecular characteristics of non-small cell lung cancer. Proc Natl Acad Sci U S A. 2001.
58. Moreno-Bueno G, Hardisson D, Sanchez C, Sarrio D, Cassia R, Garcia-Rostan G, Prat J, Guo M, Herman JG, Matias-Guiu X, Esteller M, Palacios J. Abnormalities of the APC/beta-catenin pathway in endometrial cancer. Oncogene. 21:7981-90, 2002.
59. Esteller M, Fraga MF, Paz MF, Campo E, Colomer D, Novo FJ, Calasanz MJ, Galm O, Guo M, Benitez J, Herman JG. Cancer epigenetics and methylation. Science. 297:1807-1808, 2002.
60. Laiho P, Launonen V, Lahermo P, Esteller M, Guo M, Herman JG, Mecklin JP, Jarvinen H, Sistonen P, Kim KM, Shibata D, Houlston RS, Aaltonen LA. Low-level microsatellite instability in most colorectal carcinomas. Cancer Res. 62:1166-1170, 2002.
61. Caballero OL, Resto V, Patturajan M, Meerzaman D, Guo M, Engles J, Yochem R, Ratovitski E, Sidransky D, Jen J. Interaction and colocalization of PGP9.5 with JAB1 and p27(Kip1). Oncogene. 21:3003-3010, 2002.
62. Sarrio D, Moreno-Bueno G, Hardisson D, Sanchez-Estevez C, Guo M, Herman JG, Gamallo C, Esteller M, Palacios J. Epigenetic and genetic alterations of APC and CDH1 genes in lobular breast cancer: relationships with abnormal E-cadherin and catenin expression and microsatellite instability. Int J Cancer. 106:208-215, 2003.
Book Chapter
1. Epigenetics and Tumor Suppressor Genes
by MingZhou Guo, XueFeng Liu and WeiMin Zhang in the book "Tumor Suppressor Genes" edited by Yue Cheng, ISBN 978-953-307-879-3, InTech, February 2, 2012
2. Molecular Biology Character of Esophageal Cancer
by Mingzhou Guo, Yan Jia and Wenji Yan in the book "Esophageal Cancer - Cell and Molecular Biology, Biomarkers, Nutrition and Treatment" edited by Ferdous Rastgar Jazii, ISBN 978-953-51-0223-6, InTech, March 3, 2012
